More on NBIX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $171.55 |
|
|||
| Open | $169.77 | ||||
| 52 Wk High | $58.46 | ||||
| 52 Wk Low | $31.25 | ||||
| Day High | $172.57 | ||||
| Day Low | $169.26 | ||||
| P/E | N/A | ||||
| EPS | $-0.69 | ||||
| Volume | 929,824 | ||||
- Neurocrine Bio. (NBIX) PT Raised to $200 at Wells Fargo
- Form 4 NEUROCRINE BIOSCIENCES For: Jul 07 Filed by: Delaet Ingrid
- Form 4 NEUROCRINE BIOSCIENCES For: Jul 10 Filed by: Delaet Ingrid
- Form 4 NEUROCRINE BIOSCIENCES For: Jul 09 Filed by: Lippoldt Darin
- Neurocrine Bio. (NBIX) PT Raised to $170 at BMO Capital
- Neurocrine Bio. (NBIX) PT Raised to $200 at Truist Securities
- Form 144 NEUROCRINE BIOSCIENCES Filed by: Delaet Ingrid
- Form 4 NEUROCRINE BIOSCIENCES For: Jul 07 Filed by: Delaet Ingrid
- Form 144 NEUROCRINE BIOSCIENCES Filed by: Lippoldt Darin
- Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results
Entities mentioned with NBIX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
